Non-invasive diagnostic analyzes eye movements.
An eye-tracking test for concussion that requires no baseline assessment is cleared for U.S. marketing, said neurodiagnostics company Oculogica.
To be sold as EyeBOX, the 4-minute, non-invasive test is approved for use in patients ages 5 to 67. Oculogica said it’s the first such test to win FDA marketing authorization. Patients watch a short video with their heads placed in a chin-and-forehead rest similar to those commonly used in optometry clinics. Eye movements are analyzed with a proprietary algorithm.
